BPC-157 supplied by NewBioRx is intended strictly for laboratory research use and is not approved for human or veterinary applications
Short-term (days to a few weeks) is possible but shortens shelf life significantly
In a trial of patients with T2DM and BMI 27 kg/m2 or more receiving semaglutide injection for weight management, retinal disorders were reported by 6.9% of patients treated with semaglutide 2.4 mg/week, 6.2% of patients treated with semaglutide 1 mg/week, and 4.2% of patients treated with placebo
As a general rule we would like the bottom lip to be one and a half times the size of the upper lip (or 40/60, upper to lower lip), though we can create other proportions, if the patient requests (a lip ratio of 1:1 is more popular in Latin America, and can create a beautiful, natural lip profile for many patients)
BPC-157 is stable in gastric acid and works orally, TB-500 requires injection
[ii] Krger, E., Shatokhina, E